| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1925.74 Million | USD 3903.05 Million | 7.32% | 2024 |
FrequentlyAsked Questions
The global peripheral stent implants market is expected to grow due to rising prevalence of peripheral artery disease (PAD), increasing geriatric population, advancements in stent technology, and growing demand for minimally invasive surgical procedures.
According to a study, the global peripheral stent implants market size was worth around USD 1925.74 Million in 2024 and is expected to reach USD 3903.05 Million by 2034.
The global peripheral stent implants market is expected to grow at a CAGR of 7.32% during the forecast period.
North America is expected to dominate the peripheral stent implants market over the forecast period.
Leading players in the global peripheral stent implants market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical Inc., Cardinal Health Inc., iVascular SLU, Medtronic Plc., Terumo Corporation, W. L. Gore & Associates Inc., among others.
The report explores crucial aspects of the peripheral stent implants market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients